Replies to post #192855 on Biotech Values

[DewDiligence]

BLUE sells (upsized) 3.38M* shares @$170—a 2.5% discount to yesterday’s closing price:

http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-newsArticle&ID=2062031

Net proceeds will be approximately $540M.* All told, BLUE has now raised more than $1B(!) in three offerings during the past 12 months.

*Assuming exercise of underwriter’s option.